APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2240-2243

  Xuan, Dennis ^a   Li, Guoliang ^a   Cai, Qiuyin ^a   Deming Halverson, Sandra ^a   Shrubsole, Martha ^a   Shu, Xiao Ou ^a   Kelley, Mark C ^a   Zheng, Wei ^a   Long, Jirong ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; APOBEC3 GENE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; COPY NUMBER VARIATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EUROPE; EUROPEAN AMERICAN; FEMALE; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOSINE DEAMINASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; TENNESSEE;

EID: 84885093727     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt185     Document Type: Article

References (22)

1. Zhang, B. et al. (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol., 12, 477-488.
2. Long, J. et al. (2012) Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet., 8, e1002532.
3. Michailidou, K. et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet., 45, 353-361.
4. Fletcher, O. et al. (2010) Architecture of inherited susceptibility to common cancer. Nat. Rev. Cancer, 10, 353-361.
5. Willer, C.J. et al. (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet., 41, 25-34.
6. Eichler, E.E. et al. (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet., 11, 446-450.
7. Long, J. et al. (2013) A common deletion in the APOBEC3 genes and breast cancer risk. J. Natl. Cancer Inst., 105, 573-579.
8. Livak, K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
9. Eichler, E.E. et al. (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet., 11, 446-450.
10. Suspène, R. et al. (2011) Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl Acad. Sci. USA, 108, 4858-4863.
11. Lemaire, F. et al. (2003) Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br. J. Cancer, 89, 1940-1949.
12. Xu, R. et al. (2007) Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology, 46, 1810-1820.
13. Chiu, Y.L. et al. (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol., 26, 317-353.
14. Nik-Zainal, S. et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell, 149, 979-993.
15. Roberts, S.A. et al. (2012) Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell, 46, 424-435.
16. Schlattl, A. et al. (2011) Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions. Genome Res., 21, 2004-2013.
17. Komatsu, A. et al. (2008) Identification of novel deletion polymorphisms in breast cancer. Int. J. Oncol., 33, 261-270.
18. Talagas, M. et al. (2012) Identification of a novel population in highgrade oligodendroglial tumors not deleted on 1p/19q using array CGH. J. Neurooncol., 109, 405-413.
19. An, P. et al. (2009) APOBEC3B deletion and risk of HIV-1 acquisition. J. Infect. Dis., 200, 1054-1058.
20. Celestino-Soper, P.B. et al. (2011) Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE. Hum. Mol. Genet., 20, 4360-4370.
21. Jha, P. et al. (2012) Deletion of the APOBEC3B gene strongly impacts susceptibility to falciparum malaria. Infect. Genet. Evol., 12, 142-148.
22. Zhang, T. et al. (2013) Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum. Mol. Genet., 22, 1262-1269.